These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 7218763
1. Quantitative DNCB epicutaneous sensitization in leprosy patients and controls. Sivamani S, Garg BR, Lal S. Lepr India; 1981 Jan; 53(1):45-51. PubMed ID: 7218763 [Abstract] [Full Text] [Related]
2. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants. Malhotra B, Das KD, Tutakne MA, Aggarwal SK. Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784 [Abstract] [Full Text] [Related]
4. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study. Yagnik CS, Jogaikar DG, Mehta JM. Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021 [Abstract] [Full Text] [Related]
7. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life. Cassimos C, Kanakoudi-Tsakalidis F, Spyroglou K, Ladianos M, Tzaphi R. J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930 [Abstract] [Full Text] [Related]
8. Cutaneous responses to antigens and irritants in patients of leprosy. Kumar B, Kaur S, Ganguly NK, Sharma S. Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636 [Abstract] [Full Text] [Related]
11. DNCB contact sensitization in leprosy: its comparison with other CMI tests. Jayasingh K, Bhatia VN. Indian J Lepr; 1984 Jul; 56(2):207-11. PubMed ID: 6548491 [Abstract] [Full Text] [Related]
12. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up. Munzarová M, Kovarík J, Hlávková J, Popelínský L, Lauerová L. Neoplasma; 1985 Jul; 32(1):45-50. PubMed ID: 3982560 [Abstract] [Full Text] [Related]
13. [DNCB-skin specimens for immunodiagnosis]. Sinn W. Z Gesamte Inn Med; 1981 Sep 01; 36(17):602-7. PubMed ID: 7345806 [Abstract] [Full Text] [Related]
14. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M, Malik A, Abbas SM, Vasenwala S, Kalam A. Indian J Pathol Microbiol; 1996 Jan 01; 39(1):5-12. PubMed ID: 8755125 [Abstract] [Full Text] [Related]
15. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)]. Bürkle PA, Tönnesmann E, Ahnefeld S, Nobbe F, Federlin K. Z Immunitatsforsch Exp Klin Immunol; 1976 Apr 01; 151(2):153-65. PubMed ID: 134535 [Abstract] [Full Text] [Related]
17. [Study of the DNCB skin test in patients with solid neoplasms]. Mor C, Marcovina S, Moro E, Radice F, Russo R, Trinca E. Arch Sci Med (Torino); 1978 Apr 01; 135(3):377-82. PubMed ID: 708088 [Abstract] [Full Text] [Related]
18. Cell-mediated immunity during RDT and the outcome of transplantation. Watson MA, Hamilton DN, Briggs JD, Macpherson SG, Tsakiris D. Proc Eur Dial Transplant Assoc; 1981 Apr 01; 18():387-93. PubMed ID: 7036157 [Abstract] [Full Text] [Related]